Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LASS5 Antikörper (N-Term)

LASS5 Reaktivität: Human, Maus, Ratte WB, IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN541788
  • Target Alle LASS5 Antikörper anzeigen
    LASS5 (LAG1 Homolog, Ceramide Synthase 5 (LASS5))
    Bindungsspezifität
    • 15
    • 5
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reaktivität
    • 22
    • 21
    • 7
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Human, Maus, Ratte
    Wirt
    • 35
    • 1
    Kaninchen
    Klonalität
    • 36
    Polyklonal
    Konjugat
    • 12
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser LASS5 Antikörper ist unkonjugiert
    Applikation
    • 25
    • 13
    • 13
    • 11
    • 6
    • 4
    • 3
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC)
    Verwendungszweck
    Rabbit polyclonal antibody raised against synthetic peptide of LASS5.
    Kreuzreaktivität
    Human, Maus, Ratte
    Immunogen
    A synthetic peptide corresponding to N-terminus 18 amino acids of human LASS5.
    Top Product
    Discover our top product LASS5 Primärantikörper
  • Applikationshinweise
    Western Blot (1-2 μg/mL)
    The optimal working dilution should be determined by the end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    In PBS (0.02 % sodium azide)
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for three months. For long term storage store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Separovic, Breen, Joseph, Bielawski, Pierce, VAN Buren, Gudz: "Ceramide synthase 6 knockdown suppresses apoptosis after photodynamic therapy in human head and neck squamous carcinoma cells." in: Anticancer research, Vol. 32, Issue 3, pp. 753-60, (2012) (PubMed).

    Separovic, Breen, Joseph, Bielawski, Pierce, VAN Buren, Gudz: "siRNA-mediated down-regulation of ceramide synthase 1 leads to apoptotic resistance in human head and neck squamous carcinoma cells after photodynamic therapy." in: Anticancer research, Vol. 32, Issue 7, pp. 2479-85, (2012) (PubMed).

    Spassieva, Seo, Jiang, Bielawski, Alvarez-Vasquez, Jazwinski, Hannun, Obeid: "Necessary role for the Lag1p motif in (dihydro)ceramide synthase activity." in: The Journal of biological chemistry, Vol. 281, Issue 45, pp. 33931-8, (2006) (PubMed).

    Lahiri, Futerman: "LASS5 is a bona fide dihydroceramide synthase that selectively utilizes palmitoyl-CoA as acyl donor." in: The Journal of biological chemistry, Vol. 280, Issue 40, pp. 33735-8, (2005) (PubMed).

    Riebeling, Allegood, Wang, Merrill, Futerman: "Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors." in: The Journal of biological chemistry, Vol. 278, Issue 44, pp. 43452-9, (2003) (PubMed).

  • Target
    LASS5 (LAG1 Homolog, Ceramide Synthase 5 (LASS5))
    Andere Bezeichnung
    LASS5 (LASS5 Produkte)
    Synonyme
    lass5 antikoerper, trh4 antikoerper, LASS5 antikoerper, Trh4 antikoerper, 2310081H14Rik antikoerper, AU045339 antikoerper, AW544927 antikoerper, Lass5 antikoerper, ceramide synthase 5 antikoerper, ceramide synthase 5 S homeolog antikoerper, CERS5 antikoerper, cers5 antikoerper, cers5.S antikoerper, Cers5 antikoerper
    Gen-ID
    91012
Sie sind hier:
Kundenservice